We use cookies for a better user experience. Read our Privacy Policy

I Agree

Bioprocess Technology Market

Bioprocess Technology Market (Product: Consumables & Accessories, Instruments, Cell Counter, and Others; Application and End-user) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Bioprocess Technology Market Outlook 2031

  • The global bioprocess technology market was valued at US$ 22.4 Bn in 2020
  • It is estimated to expand at a CAGR of 8.3% from 2021 to 2031
  • The global bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031

Analysts’ Viewpoint

Manufacturers in the global bioprocess technology market are capitalizing on government stimulus packages to stay financially afloat amid ongoing COVID-19 pandemic. Untapped opportunities for the treatment of chronic diseases at genetic level are helping to bridge the gap between individuals who are keen on accessing treatment alternatives. Hence, companies in the bioprocess technology market should invest in R&D to innovate in cell-level and DNA-level treatment options to increase life expectancy of patients. Although disposable systems are usually preferred in early stage development, stainless steel bioreactors are still being extensively utilized for full-scale production in North America. On the other hand, the market in Europe is being steered by the rise in demand for different products such as monoclonal antibodies, antibiotics, and biosimilars.

Biopharmaceutical Companies Boosting R&D with Surging Number of Chronic Diseases

The high prevalence of cancer and other chronic diseases is fueling the demand for innovations in the bioprocess technology. The ever-expanding pharmaceutical industry is translating into revenue opportunities for stakeholders in the global bioprocess technology market. The surge in the demand for vaccines and proteins has induced pharmaceutical and biotechnology companies to increase production of therapeutics, bolster research studies, and other investigations.

Biopharmaceutical outsourcing is emerging as a promising strategy to address the unmet medical needs among patients. This has led to rise in usage of bioprocessing systems with better process efficiency and throughput. These systems offer an advantage for adherence with regulatory compliance processes. An increasing number of biopharmaceutical companies are opting for single-use systems, as they deliver cost-efficiency and technological advancements due to growing capacities and capabilities.

Request a sample to get extensive insights into the Bioprocess Technology Market

Manufacturers Allocating Budgets to Ensure Resilient Supply Chains amid COVID-19 Pandemic

Manufacturers in the bioprocess technology market have been working at break-neck speeds amid the ongoing COVID-19 pandemic to ensure robust supply of consumables, instruments, cell counters, and the likes. As the U.S. and other regions of the world with high population such as India and Brazil are bracing themselves, Shanghai in China is yet again under great emphasis for the Wuhan virus.

Even as the production and movement of goods are slow, manufacturers are rethinking their budget for allocating sufficient capital & expenses to ensure business continuity. They are increasing the availability of life-saving medical devices to improve patient outcomes.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Investments in Bioprocess Hardware Helps Accelerate Turnaround Times

The bioprocess technology market is estimated to grow at a robust CAGR throughout the assessment period. However, this market is governed by stringent regulatory framework, since public health concerns are a top priority for CMOs (contract manufacturing organizations), CROs (contract research organizations), and CDMOs (contract development and manufacturing organizations).

Hence, stakeholders should increase R&D to expand their creation limits and reduce the turnaround time to introduce new medications in the market. Companies should invest in bioprocess hardware to offer imaginative, safe, and highly precise solutions to fulfill the expansion in need from biopharmaceutical organizations.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Bioprocess Technology Market

Cell-level Treatment Innovations Hold Potentials in Early Detection of Chronic Diseases

The lack of research for life-threatening health conditions such as the Crohn’s disease is creating opportunity windows for companies in the bioprocess technology market. Healthcare solutions at cell-level hold promising potentials to treat diseases at the foundation level. Cell-level treatment innovations have the capability to detect early symptoms of chronic diseases and can help to reduce its severity in future, thus benefitting patient quality of life. These strategies have the potential to increase life-expectancy, especially in the geriatric population. Thus, treatments that can alter the DNA at genetic level have the capability to improve patient outcomes.

Bioprocess Technology Being Enhanced with Constant R&D Activities

Constant innovations in the bioprocess technology market is leading to market expansion. Bioprocess technology finds application in end-use ventures for the assembling of biomaterials such as catalysts, anti-microbial medications, food & farming items, antibodies, and drug supplements. Moreover, this technology tracks down the application for the creation of biodegradable & climate agreeable chemicals, development of elective items to treat diseases, and facilitate the creation & assessment of more secure food materials.

As procedures and instrumentation become additionally modern, bioprocesses may find applications in different areas where substance processes are presently utilized. Biological, engineering, and mathematical processes are being pooled to achieve bioprocessing activities such as media production, biocatalysts, and the designing of bioreactor substrates. Companies in the bioprocess technology market are gaining cognizance about the benefits of the single-use bioprocessing technologies and are diversifying into the adoption for hybrid systems in their facilities.

Bioprocess Technology Market: Overview

  • Bioprocess technology is the industrial application of biological processes, which include living cells with their components to upshot the transformation of substrate
  • Bioprocess includes various activities such as biocatalyst, bioreactors, purification, upstream processes, and downstream processes
  • It has substantial demand in the pharma industry due to rise in prevalence of cancer & other chronic diseases
  • Increase in the global geriatric population leads to a rise in patient population suffering from infections and diseases. According to the 2016 research findings by the World Health Organization (WHO), population aged 60 and above is projected to reach 2.5 billion by the end of 2050.
  • More than 25% of the world’s population will be aged 65 by the end of 2050. Aging population is more prone to diseases such as chronic kidney diseases, diabetes, cardiovascular diseases, hypertension, and cancer due to low immunity. Hence, surge in the geriatric population increases the prevalence/incidence rate of these disorders and diseases.
  • Rise in outsourcing of manufacturing activities to CMOs, CROs, and CDMOs is set to propel the single-use bioprocessing industry, as increasing number of CMOs have small flexible facilities and are beginning to rely on single-use equipment in their process value chain. This is likely to boost the global bioprocess technology market.

Bioprocess Technology Market: Segmentation

  • The global bioprocess technology market has been segmented based on product, application, and end-user
  • In terms of product, the global bioprocess technology market has been bifurcated into consumables & accessories and instruments
  • Based on application, the global market has been classified into primary surgical, antibiotics, recombinant proteins, monoclonal antibodies, and biosimilar
  • In terms of end-user, the global bioprocess technology market has been divided into biopharmaceutical companies, contract manufacturing organization, contract research organization, food & feed industry, and academic research organization
  • Each of the segments has been analyzed in detail for recent trends & developments, drivers, restraints, opportunities, and useful insights. The bioprocess technology market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.

Regional Overview: Bioprocess Technology Market

  • In terms of region, the global bioprocess technology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions. North America is projected to be a highly lucrative market during the forecast period. The region accounted major share of the global market in 2020. The market in North America is anticipated to expand at a high CAGR from 2021 to 2031.
  • The U.S. dominated the market in North America in 2020, owing to factors such as increase in geriatric population and presence of a large number of bioprocess technology manufacturers. Additionally, availability of advanced technology and undertaking of a large number of research studies in the U.S. drive the market in the region.
  • Europe was the second largest market for bioprocess technology in 2020. The market in the region is driven by expansion of the biopharmaceutical industry, rise in demand for different products such as antibiotics, bio-similar, monoclonal antibodies, recombinant proteins, and cost reductions of these products.

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the global bioprocess technology market
  • Leading players analyzed in the report are
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthineers
    • GE Healthcare (General Electric Company)
    • Sartorius AG
    • Becton
    • Dickinson and Company
    • Danaher Corporation
    • Eppendorf AG
    • Lonza
    • Advanced Instruments
    • Nova Biomedical
    • F. Hoffmann-La Roche Ltd.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Bioprocess Technology Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 22.4 Bn

Market Forecast Value in 2031

US$ 53.7 Bn

Growth Rate (CAGR)

8.3%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Consumables & Accessories
      • Culture Media
      • Reagents
      • Others
    • Instruments
      • Bioprocess Analyzers
      • Blood Gas Analyzers
      • Osmometers
      • Cell Counter
      • Incubators
      • Bioreactors
      • Others (centrifugation, spectrometer, filtration)
  • Application
    • Primary Surgical
    • Antibiotics
    • Recombinant Proteins
    • Monoclonal Antibodies
    • Biosimilar
  • End-user
    • Biopharmaceutical Companies
    • Contract Manufacturing Organization
    • Contract Research Organization
    • Food & Feed Industry
    • Academic Research Organization

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • U.K.
  • France
  • Italy
  • Germany
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • South Africa
  • GCC Countries
  • Rest of Middle East & Africa

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Siemens Healthineers
  • GE Healthcare (General Electric Company)
  • Sartorius AG
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Eppendorf AG
  • Lonza
  • Advanced Instruments
  • Nova Biomedical
  • F. Hoffmann-La Roche Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Bioprocess Technology Market – Segmentation

TMR’s study on the global bioprocess technology market includes information divided into four segments: product, application, end-user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global bioprocess technology market are discussed in detail.

Product
  • Consumables & Accessories
    • Culture Media
    • Reagents
    • Others
  • Instruments
    • Bioprocess Analyzers
    • Blood Gas Analyzers
    • Osmometers
  • Cell Counter
    • Incubators
    • Bioreactors
    • Others (Centrifugation, Spectrometer, and Filtration)
  • Others
Application
  • Primary Surgical
  • Antibiotics
  • Recombinant Proteins
  • Monoclonal Antibodies
  • Biosimilar
End-user
  • Food & Feed Industry
  • Academic & Research Organizations
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Bioprocess Technology Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of bioprocess technology market?

Bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031

What is the anticipated CAGR of bioprocess technology market in forecast period?

Bioprocess technology market is estimated to expand at a CAGR of 8.3% from 2021 to 2031

What are the key driving factors for growth of the bioprocess technology market?

Bioprocess technology market is driven by rise in number of CMOs that have small flexible facilities and are beginning to rely on single-use equipment in their operations

Which region is expected to project highest market share in global bioprocess technology market?

North America accounted for a major share of the global bioprocess technology market

Who are the key players in the global bioprocess technology market?

Key players operating in the global bioprocess technology market include Thermo Fisher Scientific, Inc., Siemens Healthineers, GE Healthcare (General Electric Company), Sartorius AG, Becton

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Bioprocess Technology Market Forecast

    4.4. Global Bioprocess Technology Market Outlook

5. Market Outlook

    5.1. Technological Advancement

    5.2. List of Distributors

    5.3. Type of Analyzers Used/Preferred in the Market

    5.4. Major Assays Performed by Customers

    5.5. Pricing Analysis

    5.6. Key Brand Analysis

    5.7. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Bioprocess Technology Market Analysis and Forecast, by Product Type

    6.1. Introduction

    6.2. Global Bioprocess Technology Market Value Share Analysis, by Product Type

    6.3. Global Bioprocess Technology Market Forecast, by Product Type

        6.3.1. Consumables and Accessories

            6.3.1.1. Culture Media

            6.3.1.2. Reagents

            6.3.1.3. Others

        6.3.2. Instruments

            6.3.2.1. Bioprocess Analyzers

            6.3.2.2. Blood Gas Analyzers

            6.3.2.3. Osmometers

            6.3.2.4. Cell Counter

            6.3.2.5. Incubators

            6.3.2.6. Bioreactors

            6.3.2.7. Others (centrifugation, spectrometer, filtration)

    6.4. Global Bioprocess Technology Market Analysis, by Product Type

    6.5. Global Bioprocess Technology Market Attractiveness Analysis, by Product Type

7. Global Bioprocess Technology Market Analysis and Forecast, by Application

    7.1. Introduction

    7.2. Global Bioprocess Technology Market Value Share Analysis, by Application

    7.3. Global Bioprocess Technology Market Forecast, by Application

        7.3.1. Antibiotics

        7.3.2. Recombinant Proteins

        7.3.3. Monoclonal Antibodies

        7.3.4. Biosimilars

    7.4. Global Bioprocess Technology Market Analysis, by Application

    7.5. Global Bioprocess Technology Market Attractiveness Analysis, by Application

8. Global Bioprocess Technology Market Analysis and Forecast, by End-user

    8.1. Introduction

    8.2. Global Bioprocess Technology Market Value Share Analysis, by End-user

    8.3. Global Bioprocess Technology Market Forecast, by End-user

        8.3.1. Biopharmaceutical Companies

        8.3.2. Contract Manufacturing Organizations

        8.3.3. Contract Research Organizations

        8.3.4. Food & Feed Industry

        8.3.5. Academic & Research Organizations

    8.4. Global Bioprocess Technology Market Analysis, by End-user

    8.5. Global Bioprocess Technology Market Attractiveness Analysis, by End-user

9. Global Bioprocess Technology Market Analysis and Forecast, by Region

    9.1. Global Bioprocess Technology Market Analysis, by Region

    9.2. Global Bioprocess Technology Market Value Share and Attractiveness Analysis, by Region

    9.3. Global Bioprocess Technology Market Forecast, by Region

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

10. North America Bioprocess Technology Market Analysis

    10.1. North America Bioprocess Technology Market Overview

    10.2. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country

    10.3. North America Bioprocess Technology Market Forecast, by Country

        10.3.1. U.S.

        10.3.2. Canada

    10.4. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type

    10.5. North America Bioprocess Technology Market Forecast, by Product Type

        10.5.1. Consumables and Accessories

            10.5.1.1. Culture Media

            10.5.1.2. Reagents

            10.5.1.3. Others

        10.5.2. Instruments

            10.5.2.1. Bioprocess Analyzers

            10.5.2.2. Blood Gas Analyzers

            10.5.2.3. Osmometers

            10.5.2.4. Cell Counter

            10.5.2.5. Incubators

            10.5.2.6. Bioreactors

            10.5.2.7. Others (centrifugation, spectrometer, filtration)

    10.6. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application

    10.7. North America Bioprocess Technology Market Forecast, by Application

        10.7.1. Antibiotics

        10.7.2. Recombinant Proteins

        10.7.3. Monoclonal Antibodies

        10.7.4. Biosimilars

    10.8. North America Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user

    10.9. North America Bioprocess Technology Market Forecast, by End-user

        10.9.1. Biopharmaceutical Companies

        10.9.2. Contract Manufacturing Organizations

        10.9.3. Contract Research Organizations

        10.9.4. Food & Feed Industry

        10.9.5. Academic & Research Organizations

11. Europe Bioprocess Technology Market Analysis

    11.1. Europe Bioprocess Technology Market Overview

    11.2. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country

    11.3. Europe Bioprocess Technology Market Forecast, by Country

        11.3.1. U.K.

        11.3.2. France

        11.3.3. Italy

        11.3.4. Germany

        11.3.5. Spain

        11.3.6. Rest of Europe

    11.4. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type

    11.5. Europe Bioprocess Technology Market Forecast, by Product Type

        11.5.1. Consumables and Accessories

            11.5.1.1. Culture Media

            11.5.1.2. Reagents

            11.5.1.3. Others

        11.5.2. Instruments

            11.5.2.1. Bioprocess Analyzers

            11.5.2.2. Blood Gas Analyzers

            11.5.2.3. Osmometers

            11.5.2.4. Cell Counter

            11.5.2.5. Incubators

            11.5.2.6. Bioreactors

            11.5.2.7. Others (Centrifugation, Spectrometer, Filtration)

    11.6. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application

    11.7. Europe Bioprocess Technology Market Forecast, by Application

        11.7.1. Antibiotics

        11.7.2. Recombinant Proteins

        11.7.3. Monoclonal Antibodies

        11.7.4. Biosimilars

    11.8. Europe Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user

    11.9. Europe Bioprocess Technology Market Forecast, by End-user

        11.9.1. Biopharmaceutical Companies

        11.9.2. Contract Manufacturing Organizations

        11.9.3. Contract Research Organizations

        11.9.4. Food & Feed Industry

        11.9.5. Academic & Research Organizations

12. Asia Pacific Bioprocess Technology Market Analysis

    12.1. Asia Pacific Bioprocess Technology Market Overview

    12.2. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country

    12.3. Asia Pacific Bioprocess Technology Market Forecast, by Country

        12.3.1. China

        12.3.2. Japan

        12.3.3. India

        12.3.4. Australia & New Zealand

        12.3.5. Rest of Asia Pacific

    12.4. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type

    12.5. Asia Pacific Bioprocess Technology Market Forecast, by Product Type

        12.5.1. Consumables and Accessories

            12.5.1.1. Culture Media

            12.5.1.2. Reagents

            12.5.1.3. Others

        12.5.2. Instruments

            12.5.2.1. Bioprocess Analyzers

            12.5.2.2. Blood Gas Analyzers

            12.5.2.3. Osmometers

            12.5.2.4. Cell Counter

            12.5.2.5. Incubators

            12.5.2.6. Bioreactors

            12.5.2.7. Others (Centrifugation, Spectrometer, Filtration)

    12.6. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application

    12.7. Asia Pacific Bioprocess Technology Market Forecast, by Application

        12.7.1. Antibiotics

        12.7.2. Recombinant Proteins

        12.7.3. Monoclonal Antibodies

        12.7.4. Biosimilars

    12.8. Asia Pacific Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user

    12.9. Asia Pacific Bioprocess Technology Market Forecast, by End-user

        12.9.1. Biopharmaceutical Companies

        12.9.2. Contract Manufacturing Organizations

        12.9.3. Contract Research Organizations

        12.9.4. Food & Feed Industry

        12.9.5. Academic & Research Organizations

13. Latin America Bioprocess Technology Market Analysis

    13.1. Latin America Bioprocess Technology Market Overview

    13.2. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country

    13.3. Latin America Bioprocess Technology Market Forecast, by Country

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type

    13.5. Latin America Bioprocess Technology Market Forecast, by Product Type

        13.5.1. Consumables and Accessories

            13.5.1.1. Culture Media

            13.5.1.2. Reagents

            13.5.1.3. Others

        13.5.2. Instruments

            13.5.2.1. Bioprocess Analyzers

            13.5.2.2. Blood Gas Analyzers

            13.5.2.3. Osmometers

            13.5.2.4. Cell Counter

            13.5.2.5. Incubators

            13.5.2.6. Bioreactors

            13.5.2.7. Others (centrifugation, spectrometer, filtration)

    13.6. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application

    13.7. Latin America Bioprocess Technology Market Forecast, by Application

        13.7.1. Antibiotics

        13.7.2. Recombinant Proteins

        13.7.3. Monoclonal Antibodies

        13.7.4. Biosimilars

    13.8. Latin America Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user

    13.9. Latin America Bioprocess Technology Market Forecast, by End-user

        13.9.1. Biopharmaceutical Companies

        13.9.2. Contract Manufacturing Organizations

        13.9.3. Contract Research Organizations

        13.9.4. Food & Feed Industry

        13.9.5. Academic & Research Organizations

14. Middle East & Africa Bioprocess Technology Market Analysis

    14.1. Middle East & Africa Bioprocess Technology Market Overview

    14.2. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Country

    14.3. Middle East & Africa Bioprocess Technology Market Forecast, by Country

        14.3.1. GCC Countries

        14.3.2. South Africa

        14.3.3. Rest of Middle East & Africa

    14.4. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Product Type

    14.5. Middle East & Africa Bioprocess Technology Market Forecast, by Product Type

        14.5.1. Consumables and Accessories

            14.5.1.1. Culture Media

            14.5.1.2. Reagents

            14.5.1.3. Others

        14.5.2. Instruments

            14.5.2.1. Bioprocess Analyzers

            14.5.2.2. Blood Gas Analyzers

            14.5.2.3. Osmometers

            14.5.2.4. Cell Counter

            14.5.2.5. Incubators

            14.5.2.6. Bioreactors

            14.5.2.7. Others (centrifugation, spectrometer, filtration)

    14.6. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by Application

    14.7. Middle East & Africa Bioprocess Technology Market Forecast, by Application

        14.7.1. Antibiotics

        14.7.2. Recombinant Proteins

        14.7.3. Monoclonal Antibodies

    14.8. Middle East & Africa Bioprocess Technology Market Value Share and Attractiveness Analysis, by End-user

    14.9. Middle East & Africa Bioprocess Technology Market Forecast, by End-user

        14.9.1. Biopharmaceutical Companies

        14.9.2. Contract Manufacturing Organizations

        14.9.3. Contract Research Organizations

        14.9.4. Food & Feed Industry

        14.9.5. Academic & Research Organizations

15. Company Profiles

    15.1. Thermo Fisher Scientific, Inc.

        15.1.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.1.2. Product Portfolio

        15.1.3. Financial Overview

        15.1.4. SWOT Analysis

        15.1.5. Strategic Overview

    15.2. Siemens Healthineers

        15.2.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.2.2. Product Portfolio

        15.2.3. Financial Overview

        15.2.4. SWOT Analysis

        15.2.5. Strategic Overview

    15.3. GE Healthcare (General Electric Company)

        15.3.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.3.2. Product Portfolio

        15.3.3. Financial Overview

        15.3.4. SWOT Analysis

        15.3.5. Strategic Overview

    15.4. Sartorius AG

        15.4.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.4.2. Product Portfolio

        15.4.3. SWOT Analysis

        15.4.4. Strategic Overview

    15.5. Becton, Dickinson and Company

        15.5.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.5.2. Product Portfolio

        15.5.3. SWOT Analysis

        15.5.4. Strategic Overview

    15.6. Danaher Corporation

        15.6.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.6.2. Product Portfolio

        15.6.3. Financial Overview

        15.6.4. SWOT Analysis

        15.6.5. Strategic Overview

    15.7. Eppendorf AG

        15.7.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.7.2. Product Portfolio

        15.7.3. Financial Overview

        15.7.4. SWOT Analysis

        15.7.5. Strategic Overview

    15.8. Lonza

        15.8.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.8.2. Product Portfolio

        15.8.3. Financial Overview

        15.8.4. SWOT Analysis

        15.8.5. Strategic Overview

    15.9. Advanced Instruments

        15.9.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.9.2. Product Portfolio

        15.9.3. SWOT Analysis

        15.9.4. Strategic Overview

    15.10. Nova Biomedical

        15.10.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.10.2. Product Portfolio

        15.10.3. SWOT Analysis

        15.10.4. Strategic Overview

    15.11. F. Hoffmann-La Roche Ltd

        15.11.1. Company Overview (HQ, Business Segments, Employee Strength)

        15.11.2. Product Portfolio

        15.11.3. Financial Overview

        15.11.4. SWOT Analysis

        15.11.5. Strategic Overview

List of Tables

Table 01: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Bioprocess Technology Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 07: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031

Table 08: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 09: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 13: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031

Table 14: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 15: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Europe Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031

Table 20: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 21: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 22: Asia Pacific Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 25: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031

Table 26: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 27: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 29: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 30: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 31: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Consumables & Accessories, 2017–2031

Table 32: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 33: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 34: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Bioprocess Technology Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Bioprocess Technology Market Value Share, by Product Type (2020)

Figure 03: Global Bioprocess Technology Market Value Share, by End-user (2020)

Figure 04: Global Bioprocess Technology Market Value Share, by Application (2020)

Figure 05: Global Bioprocess Technology Market Value Share, by Region (2020)

Figure 06: Global Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 07: Global Bioprocess Technology Market Revenue (US$ Mn), by Consumables & Accessories, 2017–2031

Figure 08: Global Bioprocess Technology Market Revenue (US$ Mn), by Instruments, 2017–2031

Figure 09: Global Bioprocess Technology Market Revenue (US$ Mn), by Culture Media, 2017–2031

Figure 10: Global Bioprocess Technology Market Revenue (US$ Mn), by Reagents, 2017–2031

Figure 11: Global Bioprocess Technology Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: Global Bioprocess Technology Market Revenue (US$ Mn), by Bioprocess Analyzers, 2017–2031

Figure 13: Global Bioprocess Technology Market Revenue (US$ Mn), by Blood Gas Analyzers, 2017–2031

Figure 14: Global Bioprocess Technology Market Revenue (US$ Mn), by Osmometers, 2017–2031

Figure 15: Global Bioprocess Technology Market Revenue (US$ Mn), by Cell Counter, 2017–2031

Figure 16: Global Bioprocess Technology Market Revenue (US$ Mn), by Incubators, 2017–2031

Figure 17: Global Bioprocess Technology Market Revenue (US$ Mn), by Bioreactors, 2017–2031

Figure 18: Global Bioprocess Technology Market Revenue (US$ Mn), by Others, 2017–2031

Figure 19: Global Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 20: Global Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 21: Global Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 22: Global Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 23: Global Bioprocess Technology Market Revenue (US$ Mn), by Antibiotics, 2017–2031

Figure 24: Global Bioprocess Technology Market Revenue (US$ Mn), by Recombinant Proteins, 2017–2031

Figure 25: Global Bioprocess Technology Market Revenue (US$ Mn), by Monoclonal Antibodies, 2017–2031

Figure 26: Global Bioprocess Technology Market Revenue (US$ Mn), by Biosimilars, 2017–2031

Figure 27: Global Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 28: Global Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 29: Global Bioprocess Technology Market Revenue (US$ Mn), by Biopharmaceutical Companies, 2017–2031

Figure 30: Global Bioprocess Technology Market Revenue (US$ Mn), by Contract Manufacturing 32s, 2017–2031

Figure 31: Global Bioprocess Technology Market Revenue (US$ Mn), by Contract Research Organizations, 2017–2031

Figure 32: Global Bioprocess Technology Market Revenue (US$ Mn), by Food & Feed Industry, 2017–2031

Figure 33: Global Bioprocess Technology Market Revenue (US$ Mn), by Academic & Research Organizations, 2017–2031

Figure 34: Global Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 35: Global Bioprocess Technology Market Value Share Analysis, by Region, 2020 and 2031

Figure 36: Global Bioprocess Technology Market Attractiveness Analysis, by Region, 2021-2031

Figure 37: North America Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 38: North America Bioprocess Technology Market Value Share (%), by Country, 2020 and 2031

Figure 39: North America Bioprocess Technology Market Attractiveness Analysis, by Country, 2021–2031

Figure 40: North America Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 41: North America Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 42: North America Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031

Figure 43: North America Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 44: North America Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031

Figure 45: North America Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 46: North America Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 47: North America Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 48: North America Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: North America Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Europe Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Europe Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 52: Europe Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 53: Europe Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 54: Europe Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 55: Europe Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031

Figure 56: Europe Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 57: Europe Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031

Figure 58: Europe Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 59: Europe Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 60: Europe Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 61: Europe Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 62: Europe Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 63: Asia Pacific Bioprocess Technology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 64: Asia Pacific Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 65: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 66: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 67: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 68: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031

Figure 69: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 70: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031

Figure 71: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 72: Asia Pacific Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 73: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 74: Asia Pacific Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 75: Asia Pacific Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 76: Latin America Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 77: Latin America Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 78: Latin America Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 79: Latin America Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 80: Latin America Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 81: Latin America Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031

Figure 82: Latin America Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 83: Latin America Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031

Figure 84: Latin America Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 85: Latin America Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 86: Latin America Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 87: Latin America Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 88: Latin America Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Figure 89: Middle East & Africa Bioprocess Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 90: Middle East & Africa Bioprocess Technology Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 91: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 92: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 93: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 94: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Consumables & Accessories, 2020 and 2031

Figure 95: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Consumables & Accessories, 2021–2031

Figure 96: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Instruments, 2020 and 2031

Figure 97: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Instruments, 2021–2031

Figure 98: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by Application, 2020 and 2031

Figure 99: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by Application, 2021–2031

Figure 100: Middle East & Africa Bioprocess Technology Market Value Share Analysis, by End-user, 2020 and 2031

Figure 101: Middle East & Africa Bioprocess Technology Market Attractiveness Analysis, by End-user, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

795

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved